These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9117551)

  • 1. Neurochemical studies of Alzheimer's disease.
    Palmer AM
    Neurodegeneration; 1996 Dec; 5(4):381-91. PubMed ID: 9117551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
    Palmer AM; Francis PT; Bowen DM; Benton JS; Neary D; Mann DM; Snowden JS
    Brain Res; 1987 Jun; 414(2):365-75. PubMed ID: 3620938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical correlates of dementia.
    Procter AW
    Neurodegeneration; 1996 Dec; 5(4):403-7. PubMed ID: 9117554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B; Messamore E; O'Neill C; Cowburn R
    Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic markers and neurochemical correlates of agitation and psychosis in dementia.
    Kirby M; Lawlor BA
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S2-7. PubMed ID: 8561841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM; Yates PO
    Hum Neurobiol; 1986; 5(3):147-58. PubMed ID: 2876973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease.
    Palmer AM; Procter AW; Stratmann GC; Bowen DM
    Neurosci Lett; 1986 May; 66(2):199-204. PubMed ID: 3014387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.
    Lowe SL; Bowen DM; Francis PT; Neary D
    Neuroscience; 1990; 38(3):571-7. PubMed ID: 1980143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine neurons in aging and Alzheimer's disease.
    Palmer AM; DeKosky ST
    J Neural Transm Gen Sect; 1993; 91(2-3):135-59. PubMed ID: 8099796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
    Bowen DM; Allen SJ; Benton JS; Goodhardt MJ; Haan EA; Palmer AM; Sims NR; Smith CC; Spillane JA; Esiri MM; Neary D; Snowdon JS; Wilcock GK; Davison AN
    J Neurochem; 1983 Jul; 41(1):266-72. PubMed ID: 6306169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaceutical research strategies in Alzheimer's disease].
    Wülfert E
    J Pharm Belg; 1991; 46(1):67-77. PubMed ID: 2051302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical basis of dementia in Parkinson's disease.
    Hornykiewicz O; Kish SJ
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):185-90. PubMed ID: 6143610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurochemistry of Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
    J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.
    Palmer AM; Francis PT; Benton JS; Sims NR; Mann DM; Neary D; Snowden JS; Bowen DM
    J Neurochem; 1987 Jan; 48(1):8-15. PubMed ID: 2432177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.